Ligand Pharmaceuticals Incorporated announced that John Higgins will resign as a director of the company on December 31, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
78.59 USD | -0.39% |
|
-1.58% | +9.98% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.98% | 1.42B | |
+55.26% | 815B | |
+44.25% | 654B | |
-6.55% | 354B | |
+21.92% | 337B | |
+10.67% | 302B | |
+18.45% | 247B | |
+2.09% | 229B | |
+13.03% | 219B | |
+9.42% | 171B |
- Stock Market
- Equities
- LGND Stock
- News Ligand Pharmaceuticals Incorporated
- Ligand Pharmaceuticals Incorporated Announces the Resignation of John Higgins as Director, Effective December 31, 2022